Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)

Last updated: February 26, 2025
Sponsor: University of British Columbia
Overall Status: Completed

Phase

4

Condition

Asthma

Treatment

Exercise

Placebo medication

Salbutamol

Clinical Study ID

NCT05087693
H21-01080
  • Ages 18-50
  • All Genders

Study Summary

Salbutamol use is increased in areas with high levels of ozone pollution and the potential consequences of this are not well known. The purpose of this study is to examine the effect of salbutamol on lung function and inflammation in people with asthma and/or EIB exercising in ozone air pollution. To examine this, we are planning a randomized cross over trial where people with asthma and/or EIB complete sub maximal exercise in four conditions on four separate days. The four condition are: ozone + salbutamol, filtered air + salbutamol, ozone + placebo medication, and filtered air + placebo medication.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Have asthma and/or EIB

  • Able to perform maximal exercise

  • Able to communicate sufficiently using the English language

Exclusion

Exclusion Criteria:

  • Allergic to salbutamol (also known as Ventolin)

  • Pregnant or potentially pregnant

  • Have a history of smoking

  • Had an upper respiratory tract infection within the last 4 weeks

  • Have a chronic respiratory disease other than asthma or EIB

Study Design

Total Participants: 18
Treatment Group(s): 5
Primary Treatment: Exercise
Phase: 4
Study Start date:
November 01, 2021
Estimated Completion Date:
August 31, 2023

Connect with a study center

  • Environmental Physiology Laboratory

    Vancouver, British Columbia V6T 1Z1
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.